{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:02:28Z","timestamp":1790805748398,"version":"4.1.0"},"reference-count":23,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Cancer Institue","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cancer Biology & Therapy"],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1080\/15384047.2018.1523857","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T14:07:54Z","timestamp":1539266874000},"page":"247-251","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL)"],"prefix":"10.1080","volume":"20","author":[{"given":"Natalie","family":"Galanina","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology","place":["San Diego, USA"]},{"name":"University of California San Diego, Moores Cancer Center","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-1214","authenticated-orcid":false,"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology","place":["San Diego, USA"]},{"name":"University of California San Diego, Moores Cancer Center","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"e_1_3_9_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7524"},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.09.002"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1140760"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_9_7_1","article-title":"Next generation sequencing reveals potentially actionable alterations in the majority of patients with lymphoid malignancies","volume":"1","author":"Goodman AM","year":"2017","unstructured":"Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. Next generation sequencing reveals potentially actionable alterations in the majority of patients with lymphoid malignancies. JCO Precis Oncol. 2017;1.","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.3780"},{"key":"e_1_3_9_9_1","article-title":"Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): an MD Anderson precision medicine study","volume":"2017","author":"Tsimberidou AM","year":"2017","unstructured":"Tsimberidou AM, Hong DS, Ye Y, Cartwright C, Wheler JJ, Falchook GS, Naing A, Fu S, Piha-Paul S, Janku F, et al. Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): an MD Anderson precision medicine study. JCO Precis Oncol. 2017;2017.","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0199"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1569"},{"key":"e_1_3_9_12_1","first-page":"2971","article-title":"Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS","volume":"59","author":"Beaupre DM","year":"1999","unstructured":"Beaupre DM, Talpaz M, Marini FC 3rd, Cristiano RJ, Roth JA, Estrov Z, Albitar M, Freedman MH, Kurzrock R. Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS. Cancer Res. 1999;59:2971\u20132980.","journal-title":"Cancer Res"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.4223"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2782"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.583.583"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.3014"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11730"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1713676"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0405"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.920"}],"container-title":["Cancer Biology & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15384047.2018.1523857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/15384047.2018.1523857","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15384047.2018.1523857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:38:38Z","timestamp":1790804318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15384047.2018.1523857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,4]]}},"alternative-id":["10.1080\/15384047.2018.1523857"],"URL":"https:\/\/doi.org\/10.1080\/15384047.2018.1523857","relation":{},"ISSN":["1538-4047","1555-8576"],"issn-type":[{"value":"1538-4047","type":"print"},{"value":"1555-8576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kcbt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kcbt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}